Ferium 500 Injection contains Ferric Carboxymaltose (50mg/ml), a parenteral iron preparation used to treat iron deficiency anemia, particularly in patients who cannot tolerate oral iron therapy or require rapid iron replenishment. This injectable formulation provides a stable complex of ferric iron and carboxymaltose, allowing controlled release and efficient uptake by the reticuloendothelial system, facilitating effective restoration of iron stores. Ferium 500 is indicated for the treatment of iron deficiency anemia associated with chronic kidney disease, heavy uterine bleeding, postpartum anemia, or other conditions where oral iron is ineffective or contraindicated. The injection is administered intravenously, enabling higher doses of iron to be delivered in a single session, reducing the need for multiple administrations and improving patient compliance. Common side effects may include transient headache, dizziness, nausea, or injection site reactions, but serious adverse events are rare when used as directed. Ferium 500 should be used cautiously in patients with known hypersensitivity to iron products or those with iron overload disorders. Monitoring of iron status and hemoglobin levels is recommended during therapy to avoid iron toxicity. Overall, Ferium 500 Injection offers a safe and effective option for rapid correction of iron deficiency anemia in diverse clinical settings.